Related Experiment Video
Updated: Dec 19, 2025

A Proximal Culture Method to Study Paracrine Signaling Between Cells
Published on: August 28, 2018
ERBB2 gene expression silencing involved in ovarian cancer cell migration and invasion through mediating MAPK1/MAPK3
1Department of Gynaecology, Liaoning Cancer Hospital & Institute, Cancer Hospital of China Medical University, Shenyang, Liaoning Province, P.R. China. 450185112@126.com.
Objective:
To explore possible mechanism of ERBB2 gene expression silencing mediating mitogen-activated protein kinase 1/mitogen-activated protein kinase 3 (MAPK1/MAPK3) signaling pathway on proliferation, migration, and invasion of ovarian cancer cells.
Patients And Methods:
A total of 240 cancer specimens were collected in patients with epithelial ovarian cancer intraoperatively in our hospital from January 2015 to January 2018. Expressions of ERBB2, MAPK1, and MAPK3 in tissues were detected by immunohistochemistry. Following the culture of ovarian cancer cell lines, target cell line with high expression of ERBB2 was screened by qRT-PCR. Cell grouping was performed with four groups after transfection, including Blank group, negative control (NC) group, ERBB2 shRNA group, and ERBB2 overexpression group (shorted as ERBB2 group). The expression levels of ERBB2, MAPK1, MAPK3, vascular endothelial growth factor (VEGF), metalloproteases-2 (MMP-2), and tissue inhibitor of metalloproteases-2 (TIMP-2) were detected by qRT-PCR in different transfection groups, followed by the detection of protein expressions with Western blot. 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay was used to test the proliferation activity of each group after transfection, while transwell assay and scratch test explored cell invasion and migration in each group, respectively.
Results:
Immunohistochemistry showed that the positive rates of ERBB2, MAPK1, and MAPK3 in ovarian cancer tissues were significantly increased than those in adjacent normal epithelial tissues. In the cell experiment, ERBB2 gene was highly expressed in SKOV3 ovarian cancer cell line. There was no significant difference in each index between Blank group and NC group (p > 0.05). Compared with Blank group and NC group, the expression levels of ERBB2, MAPK1, MAPK3, VEGF, and MMP-2 in ERBB2 shRNA group decreased significantly, TIMP-2 increased markedly, and proliferation, invasion, and migration abilities of cells decreased markedly after transfection, showing statistically significant differences (All p < 0.05). By contrast, the expression levels of ERBB2, MAPK1, MAPK3, VEGF, and MMP-2 increased remarkably in ERBB2 group, while TIMP-2 decreased significantly, and cell proliferation, invasion, and migration ability increased evidently after transfection, with statistically significant differences (All p < 0.05).
Conclusions:
Silencing ERBB2 gene expression may inhibit the activation of MAPK1/MAPK3 signaling pathway and thus suppress the proliferation, invasion, and migration of ovarian cancer cells. Overexpression of ERBB2 gene can reverse those trends, which in turn support the role of ERBB2 gene expression silencing in molecular targeted therapy of ovarian cancer.
Insights
Silencing ERBB2 gene expression inhibits ovarian cancer cell proliferation, invasion, and migration by suppressing the MAPK1/MAPK3 pathway. This finding supports ERBB2 gene silencing as a potential molecular targeted therapy for ovarian cancer.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- ERBB2 gene amplification and overexpression are implicated in various cancers.
- The mitogen-activated protein kinase 1/3 (MAPK1/MAPK3) pathway plays a crucial role in cell proliferation, migration, and invasion.
- Understanding the interplay between ERBB2 and MAPK1/MAPK3 signaling is vital for developing targeted ovarian cancer therapies.
Purpose of the Study:
- To investigate the mechanism by which ERBB2 gene expression silencing affects the MAPK1/MAPK3 signaling pathway.
- To determine the impact of ERBB2 modulation on ovarian cancer cell proliferation, migration, and invasion.
Main Methods:
- Immunohistochemistry was used to assess ERBB2, MAPK1, and MAPK3 expression in 240 ovarian cancer tissues.
- Ovarian cancer cell lines were transfected with ERBB2 shRNA or an ERBB2 overexpression vector.
- Quantitative real-time PCR (qRT-PCR) and Western blot analyzed gene and protein expression.
- MTT assay, Transwell assay, and scratch test evaluated cell proliferation, invasion, and migration.
Main Results:
- ERBB2, MAPK1, and MAPK3 were significantly upregulated in ovarian cancer tissues compared to normal tissues.
- ERBB2 gene silencing in SKOV3 cells led to decreased expression of ERBB2, MAPK1, MAPK3, VEGF, and MMP-2, and increased TIMP-2.
- Silencing ERBB2 significantly reduced ovarian cancer cell proliferation, invasion, and migration.
- ERBB2 overexpression reversed these effects, increasing proliferation, invasion, and migration.
Conclusions:
- ERBB2 gene expression silencing inhibits ovarian cancer cell proliferation, invasion, and migration by suppressing the MAPK1/MAPK3 signaling pathway.
- ERBB2 plays a critical role in promoting ovarian cancer progression.
- ERBB2 gene silencing represents a promising strategy for molecular targeted therapy in ovarian cancer.
More Related Videos
09:40Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer
Published on: August 2, 2024
09:08Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer
Published on: January 12, 2020
Related Concept Videos
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
MAPK Signaling Cascades
Mitogens and the Cell Cycle
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Cancer Cell Migration through Invadopodia
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...